112 related articles for article (PubMed ID: 26096232)
1. The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis.
Yang B; Wang D; Chen H; Yang F
Niger J Clin Pract; 2015; 18(5):577-83. PubMed ID: 26096232
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
Kim HS; Kim TH; Chung HH; Song YS
Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?
Bounous VE; Ferrero A; Fuso L; Ravarino N; Ceccaroni M; Menato G; Biglia N
Anticancer Res; 2016 Jul; 36(7):3445-9. PubMed ID: 27354606
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
5. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
6. Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis.
Chen P; Zhang CY
Front Oncol; 2022; 12():732322. PubMed ID: 35433452
[TBL] [Abstract][Full Text] [Related]
7. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
[TBL] [Abstract][Full Text] [Related]
8. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
10. Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?
Dinkelspiel HE; Matrai C; Pauk S; Pierre-Louis A; Chiu YL; Gupta D; Caputo T; Ellenson LH; Holcomb K
Cancer Invest; 2016; 34(3):148-54. PubMed ID: 26986692
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
[TBL] [Abstract][Full Text] [Related]
12. Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis.
Lu J; Tao X; Zhou J; Lu Y; Wang Z; Liu H; Xu C
Oncotarget; 2017 Jan; 8(4):5843-5852. PubMed ID: 27992377
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.
Xu K; Yang S; Zhao Y
Oncotarget; 2017 Jan; 8(1):285-302. PubMed ID: 27690218
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China.
He ZX; Shi HH; Fan QB; Zhu L; Leng JH; Sun DW; Li ZF; Shen K; Wang S; Lang JH
J Ovarian Res; 2017 Jul; 10(1):45. PubMed ID: 28716151
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
Wu YS; Shui L; Shen D; Chen X
Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
Yu L; Deng L; Li J; Zhang Y; Hu L
Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
[TBL] [Abstract][Full Text] [Related]
20. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
